Insulin-like growth factor 2 (IGF-2) rescues social deficits in NLG3-/y mouse model of ASDs

Autism spectrum disorders (ASDs) comprise developmental disabilities characterized by impairments of social interaction and repetitive behavior, often associated with cognitive deficits.There is no current treatment that can ameliorate most of the ASDs symptomatology; thus, identifying novel therapi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pizzarelli, Rocco (VerfasserIn) , Pimpinella, Domenico (VerfasserIn) , Jacobs, Christian (VerfasserIn) , Tartacca, Alice (VerfasserIn) , Kullolli, Uarda (VerfasserIn) , Monyer, Hannah (VerfasserIn) , Alberini, Cristina M. (VerfasserIn) , Griguoli, Marilena (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 January 2024
In: Frontiers in cellular neuroscience
Year: 2024, Jahrgang: 17, Pages: 1-11
ISSN:1662-5102
DOI:10.3389/fncel.2023.1332179
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fncel.2023.1332179
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fncel.2023.1332179
Volltext
Verfasserangaben:Rocco Pizzarelli, Domenico Pimpinella, Christian Jacobs, Alice Tartacca, Uarda Kullolli, Hannah Monyer, Cristina M. Alberini and Marilena Griguoli
Beschreibung
Zusammenfassung:Autism spectrum disorders (ASDs) comprise developmental disabilities characterized by impairments of social interaction and repetitive behavior, often associated with cognitive deficits.There is no current treatment that can ameliorate most of the ASDs symptomatology; thus, identifying novel therapies is urgently needed. Here, we used the Neuroligin 3 knockout mouse (NLG3 -/y ), a model that recapitulates the social deficits reported in ASDs patients, to test the effects of systemic administration of IGF-2, a polypeptide that crosses the blood-brain barrier and acts as a cognitive enhancer. We show that systemic IGF-2 treatment reverses the typical defects in social interaction and social novelty discrimination reflective of ASDs-like phenotypes. This effect was not accompanied by any change in spontaneous glutamatergic synaptic transmission in CA2 hippocampal region, a mechanism found to be crucial for social novelty discrimination. However, in both NLG3 +/y and NLG3 -/y mice IGF-2 increased cell excitability. Although further investigation is needed to clarify the cellular and molecular mechanisms underpinning IGF-2 effect on social behavior, our findings highlight IGF-2 as a potential pharmacological tool for the treatment of social dysfunctions associated with ASDs.
Beschreibung:Gesehen am 18.06.2024
Im Titel ist der Ausdruck "-/y" hochgestellt
Beschreibung:Online Resource
ISSN:1662-5102
DOI:10.3389/fncel.2023.1332179